Publication | Closed Access

Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment

Metabolic SyndromeThrombosisHealth PolicyCardiovascular DiseaseSecondary Prevention TreatmentDiabetesHyperlipidemiaVascular BiologyPublic HealthMedicineStable AnginaAtherosclerosisClinical OutcomeDyslipidemiaCoronary Artery DiseaseAnesthesiology